Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Sahar S Abdelmoneim , Sharon L Mulvagh Added: 3 years ago
Several advances in the field of echocardiography have led to improvements in the accuracy of stress echocardiography (SE) and further strengthened its established diagnostic and prognostic role in patients with known or suspected coronary artery disease (CAD). 1,2 In addition to its role in CAD, SE can be used to assess the severity of valvular heart disease and for detection of occult pulmonary… View more

Imaging & Diagnostics
Research Area(s) / Expertise:

Hypertension

 Job title: Consultant Cardiologist
Dr Smith qualified in 1994 from Guy’s and St Thomas’ Hospitals, London. He trained in general & interventional cardiology at the Manchester Heart Centre (Manchester Royal Infirmary) and The London Chest Hospital. Dr Smith was appointed as a consultant in 2008 and works at Barts Heart Centre (Barts Health NHS Trust) and Royal Free Hospitals Foundation Trust as an interventional Cardiologist. He… View more
Jeffrey J Popma
Dr Popma graduated from the Indiana University School of Medicine in 1981. He works in Boston, MA, and specialises in cardiovascular disease. Dr. Popma is affiliated with Beth Israel Deaconess Hospital Milton and Beth Israel Deaconess Medical Center West Campus. Clinical Interests Interventional cardiology Radial artery catheterisation Complex coronary stent placement Atherectomy Left ventricular… View more
Dr Douglas Fraser trained preclinical in Oxford and clinical in Cambridge, qualifying in 1991. House jobs in Addenbrooke’s, SHO and registrar training in the West Midlands including QE Birmingham, Walsgrave Coventry, North Staffordshire. One year fellowship in Amsterdam. Recognised as expert in radial angioplasty. Active publication record in interventional cardiology View more
TCT 23: IFR SWEDEHEART
Author(s): Matthias Gotberg Added: 5 months ago
TCT 23 - We are joined by Dr Matthias Götberg (Lund University, SE) to discuss recent findings from a study of the SWEDEHEART Registry, where the long-term outcomes of iFR vs FFR guided coronary revascularization were compared. Results suggest that in a national registry analysis of 42887 patients investigated with iFR or FFR with 5-year follow-up, similar outcomes were observed in MACE, all… View more

Prevention & Chronic Conditions

Intervention
TCT 22: Sentinel® Stroke Protection System During TAVR
Author(s): Samir R Kapadia Added: 1 year ago
TCT 22 - In this short interview, Dr Samir Kapadia (Cleveland Clinic, OH, US) outlines the findings of the PROTECTED-TAVR trial, which aimed to demonstrate the performance of Boston Scientific's Sentinel® Cerebral Protection System in transcatheter aortic valve replacement. In this study, 3000 patients were randomized to receive either TAVR with the Sentinel system or TAVR without intervention… View more

Prevention & Chronic Conditions

Intervention
ESC 22: PERSPECTIVE: Sacubitril/Valsartan & Cognitive Function in HFmrEF &
Author(s): John JV McMurray Added: 1 year ago
ESC Congress – Prof John McMurray (University of Glasgow, UK) joined us to discuss the finding of the PERSPECTIVE trial (NCT02884206). The trial assessed whether the angiotensin receptor-neprilysin inhibitor (ARNi), sacubitril/valsartan (Novartis) has any negative impact on cognitive function in people who have heart failure with preserved ejection fraction (HFpEF) when compared with HFpEF… View more

Heart Failure
TCT 23: 5Y Outcomes From the PARTNER 3 Low-Risk Trial
Author(s): Martin B Leon Added: 4 months ago
TCT 23 - In this short virtual interview, we are joined by Dr Martin B Leon (Columbia University Medical Center, US) to discuss the 5-year outcomes from Edwards' PARTNER 3 low-risk trial (NCT02675114).PARTNER 3 is a randomized, prospective, multicenter trial that aimed to determine the safety and effectiveness of the SAPIEN 3 transcatheter heart valve in patients with severe calcific aortic… View more

Intervention
TCT 23: Four-Year Outcomes from the EVOLUT Low Risk Trial
Author(s): Michael J Reardon Added: 5 months ago
TCT 23 - In this succinct interview, we are joined by Dr Michael Reardon (Houston Methodist, US) to discuss the four-year outcomes from the EVOLUT Low-Risk Trial (NCT03635424), sponsored by Medtronic. The EVOLUT Low-risk trial is a multicenter, prospective, single-arm study which aimed to assess the procedural safety and efficacy of the Medtronic TAVR system in 150 patients with bicuspid… View more

Intervention
Shockwave and Non-transfemoral Transcatheter Aortic Valve Replacement
Author(s): Eden C Payabyab , Lindsay S Elbaum , Navneet Sharma , et al Added: 2 years ago

Vascular Disease and Surgery